HealthCor Management’s Avanos Medical AVNS Stock Holding History

HealthCor Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-627,500	Closed	-$28.9M	–	54
2018 Q1	$28.9M	Buy	+627,500	New	+$29.8M	0.98%	33
2015 Q2	–	Sell	-620,800	Closed	-$30.5M	–	58
2015 Q1	$30.5M	Sell	620,800 -330,000	-35%	-$15.3M	1.46%	30
2014 Q4	$43.2M	Buy	+950,800	New	+$37.4M	2.41%	18

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

HealthCor Management's AVNS Position: Q2 2018 in Review

HealthCor Management sold out of Avanos Medical (AVNS) in Q2 2018, closing a stake of 627,500 shares — an estimated $28.9M sold.

HealthCor Management first reported a position in AVNS in Q4 2014 and held it in 3 quarters. The position peaked at $43.2M in Q4 2014. 321 funds tracked by Wall St. Rank hold AVNS as of Q2 2018.

HealthCor Management reported no remaining Avanos Medical position as of Q2 2018 after selling out during the quarter.
HealthCor Management sold 627,500 Avanos Medical shares in Q2 2018, an estimated $28.9M.
HealthCor Management first reported a position in Avanos Medical in Q4 2014 and held it in 3 quarters.
HealthCor Management's Avanos Medical position peaked at $43.2M in Q4 2014.
321 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2018.

Based on HealthCor Management's 13F filing for Q2 2018, filed 14 Aug 2018.